- Home
- COFS vs ALDX Comparison
COFS vs ALDX Comparison
Compare COFS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COFS
- ALDX
- Stock Information
- Founded
- COFS 1898
- ALDX 2004
- Country
- COFS United States
- ALDX United States
- Employees
- COFS N/A
- ALDX N/A
- Industry
- COFS Major Banks
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- COFS Finance
- ALDX Health Care
- Exchange
- COFS Nasdaq
- ALDX Nasdaq
- Market Cap
- COFS 426.9M
- ALDX 160.8M
- IPO Year
- COFS N/A
- ALDX 2014
- Fundamental
- Price
- COFS $29.76
- ALDX $4.76
- Analyst Decision
- COFS Strong Buy
- ALDX Strong Buy
- Analyst Count
- COFS 2
- ALDX 2
- Target Price
- COFS $39.00
- ALDX $9.50
- AVG Volume (30 Days)
- COFS 177.3K
- ALDX 1.2M
- Earning Date
- COFS 07-24-2025
- ALDX 07-31-2025
- Dividend Yield
- COFS 3.71%
- ALDX N/A
- EPS Growth
- COFS N/A
- ALDX N/A
- EPS
- COFS 0.80
- ALDX N/A
- Revenue
- COFS $88,657,000.00
- ALDX N/A
- Revenue This Year
- COFS $76.63
- ALDX N/A
- Revenue Next Year
- COFS $10.50
- ALDX N/A
- P/E Ratio
- COFS $37.71
- ALDX N/A
- Revenue Growth
- COFS 10.12
- ALDX N/A
- 52 Week Low
- COFS $24.89
- ALDX $1.14
- 52 Week High
- COFS $38.15
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- COFS 59.29
- ALDX 78.74
- Support Level
- COFS $29.75
- ALDX $4.12
- Resistance Level
- COFS $30.69
- ALDX $4.60
- Average True Range (ATR)
- COFS 0.70
- ALDX 0.29
- MACD
- COFS 0.15
- ALDX 0.08
- Stochastic Oscillator
- COFS 81.15
- ALDX 90.91
About COFS ChoiceOne Financial Services Inc.
ChoiceOne Financial Services Inc is a full-service banking institution. It is engaged in the business of providing personal and business banking solutions, borrowing solutions, and treasury notes and bonds services. The bank's product and services portfolio consist of time, savings and demand deposits, safe deposit services, automated transaction machine services, commercial and consumer loans, commercial lending to business, industry, agricultural, construction, inventory, and real estate categories. Its primary market area is Kent, Muskegon, Newaygo, and Ottawa counties in western Michigan, and Lapeer, Macomb, and St. Clair counties in southeastern Michigan in the communities where the Bank's respective offices are located.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.